Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease.
Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease.
复制标题
(-)-表没食子儿茶素-3-没食子酸酯治疗非酒精性脂肪肝的潜在生物学效应
DOI:
10.1002/mnfr.201700483
复制
发表时间:
2018-01
影响因子:
5.2
通讯作者:
Feng Q
中科院分区:
文献类型:
--
作者:
Chen C;Liu Q;Liu L;Hu YY;Feng Q
Nonalcoholic fatty liver disease (NAFLD) is a major health issue throughout the world. However, no validated treatments for NAFLD are currently available. In‐depth studies have demonstrated the efficacy of (‐)‐epigallocatechin‐3‐gallate (EGCG), a main bioactive chemical extracted from green tea, in treating NAFLD. EGCG exhibits multi‐pronged preventive and therapeutic activities, including promoting lipid and glucose metabolism, anti‐lipid peroxidation and anti‐inflammation activities, anti‐fibrosis, and anti‐NAFLD related tumor, thus contributing to the mitigation of NAFLD occurrence and progression. The objectives of this paper are to review and discuss the currently known targets, signaling pathways and roles of EGCG that interfere with NAFLD pathogenesis, then providing additional experimental evidence and the foundation for the further studies and clinical applications of EGCG in the prevention and treatment of NAFLD.
登录
查看更多内容
DOI:
10.1093/jn/138.9.1677
发表时间:
2008-09
期刊:
The Journal of nutrition
影响因子:
--
作者:
Bose M;Lambert JD;Ju J;Reuhl KR;Shapses SA;Yang CS
通讯作者:
Yang CS
影响因子:
6.3
作者:
Hsu, Chung-Hua;Tsai, Tung-Hu;Chou, Pesus
通讯作者:
Chou, Pesus
影响因子:
6.1
作者:
Bursill, CA;Roach, PD
通讯作者:
Roach, PD
影响因子:
3
作者:
Haque, Rizwanul;Nazir, Aamir
通讯作者:
Nazir, Aamir
影响因子:
4.8
作者:
Henriksen BS;Curtis ME;Fillmore N;Cardon BR;Thomson DM;Hancock CR
通讯作者:
Hancock CR